Purchase Order 75N95019P00388
Award Date 6/24/19
Potential Completion Date 8/30/19
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Gaithersburg, MD 20879, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $18,000 firm fixed price purchase order was awarded by the National Institutes of Health's National Institute on Drug Abuse to Codex Biosolutions Inc., a minority-owned small business located in Gaithersburg, Maryland. Codex Biosolutions provides cell-based assay products and services to support research and development activities for government agencies, pharmaceutical companies, and other institutes. Under this contract, Codex is tasked with delivering specialized cell lines,...
- This is a $29,400 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Dexorgen Inc., doing business as Codex Biosolutions Inc. Codex Biosolutions is a minority-owned, small disadvantaged business that specializes in advanced biotechnological research, particularly in cell line development, genetic engineering, and translational science support. The contract,...
- This contract was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Codex Biosolutions Inc., a minority-owned small business located in Gaithersburg, Maryland. The $18,060 firm fixed-price purchase order is for screening services to identify small molecule antagonists of the GPR17 receptor, which is involved in various diseases. Codex Biosolutions specializes in cell-based assays and has received numerous NIH contracts for research and...
- This is a $13,200 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Dexorgen Inc., doing business as Codex Biosolutions Inc. The contract is for the development and optimization of antagonist assays in cells expressing different variants of the ACVR1 gene. Codex Biosolutions is a minority-owned small disadvantaged business located in Gaithersburg, Maryland that...
- Codex Biosolutions Inc. Research and Development Division, doing business as Codex Biosolutions Inc., has been awarded a $18,400 firm fixed-price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to provide cell line generation services. The contract has a period of performance of September 1, 2023 through August 31, 2024 and will be performed in Gaithersburg, Maryland. No set-aside designation or subcontractors were indicated. The award...
- The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $35,025 firm fixed price purchase order to Codex Biosolutions Inc. under a non-competitive solicitation. Codex will generate a stable P/Q type calcium channel CaV2.1 cell line by cloning specified channel proteins into HEK293 cells and introducing an additional channel to control calcium flux, as described in the attached statement of work. The one-year contract has a period of performance from...
- This federal contract award with ID 75N95020P00247 was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to 10X Genomics, Inc., a small business, for the procurement of reagents for single-cell RNA sequencing analysis experiments. The $49,776.00 firm-fixed price purchase order is supporting the agency's research efforts related to the Coronavirus COVID-19 national emergency. The award...
- The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $25,770.00 firm-fixed price purchase order to Dexorgen Inc., dba Codex Biosolutions Inc., a minority-owned small business, to provide HTLV envelope protein production services. The purpose is to construct stable cell lines to increase yields of HTLV-1 envelope proteins for structural analysis and research conducted by the Vaccine Research Center (VRC). This sole-source...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $204,000.00 firm fixed price purchase order to Laboratories Nexelis Canada Inc. (doing business as Pairimmune), a for-profit organization, to acquire 20 pseudoparticles (30ml each) to support SARS-CoV-2 research for the DPI_SARS-COV-2_VARIANT TRACE project. The award was not set aside and has a completion date of April 30, 2022. Nexelis Group Inc., the parent company of the...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to 10X Genomics, Inc., a for-profit manufacturer of life sciences products and services. The contract is valued at $112,686.00 and is set aside for small businesses. It is for the provision of single cell RNA library and sequencing reagent kits in support of the National Interest Action related to the Coronavirus...